| Literature DB >> 31475078 |
Anisa Mburu1, Peter Itsura2, Hillary Mabeya2, Alice Kaaria3, Darron R Brown4.
Abstract
Cervical cancer is a critical public health concern in sub-Saharan Africa. Adolescents are key targets in primary prevention strategies. Following a human papillomavirus (HPV) vaccination initiative (Gardasil) in Eldoret, Kenya, the knowledge and source of information of cervical cancer and acceptance of prevention strategies among vaccinated and unvaccinated adolescents were evaluated. A cross-sectional comparative study enrolled 60 vaccinated and 120 unvaccinated adolescent women. Institutional ethical approval was obtained and signed consent was obtained from the parents. Data collection was performed using interviewer-administered questionnaires derived from factual statements based on information from print material used for community sensitization on cervical cancer. The median age of the participants was 14.0 years (interquartile range [IQR] = 13.0-15.0). Of 60 vaccinated adolescents, 56 (93.3%) had heard of the HPV vaccine compared with 6 (5%) of unvaccinated participants (p < 0.001). Of 60 vaccinated participants, 58 (96.7%) had heard of cervical cancer compared with 61 (50.8%) unvaccinated participants (p < 0.001). Both cohorts identified the school as the main source of information for cervical cancer. The two groups also showed similarity in their selection of cervical cancer prevention strategies acceptable to them such as delaying sexual debut, limiting number of sexual partners, and use of condoms for protection against sexually transmitted infections. Of 120 unvaccinated participants, 63.7% expressed willingness to be vaccinated. Exposure to the HPV vaccine was associated with a higher knowledge of cervical cancer. The adolescents predominantly rely on the school for health information. Both cohorts of adolescents showed remarkable acceptability for cervical cancer prevention strategies.Entities:
Keywords: HPV vaccine; Kenya; acceptability; adolescents; knowledge
Year: 2019 PMID: 31475078 PMCID: PMC6715544 DOI: 10.1089/biores.2019.0007
Source DB: PubMed Journal: Biores Open Access ISSN: 2164-7844
Comparison of Knowledge of Cervical Cancer, Human Papillomavirus and its Risk Factors
| Variable | Vaccinated | p[ | |
|---|---|---|---|
| No ( | Yes ( | ||
| Participants, | |||
| General knowledge | |||
| Heard of cervical cancer (yes) | 61 (50.8) | 58 (96.7) | <0.001 |
| Heard of HPV vaccine (yes) | 6 (5.0) | 56 (93.3) | <0.001 |
| HPV transmission | |||
| Sexual contact (correctly responded yes) | 6 (5.0) | 25 (41.7) | <0.001 |
| Blood transfusion (incorrectly responded yes) | 6 (5.0) | 8 (13.3) | 0.074 |
| Don't know | 108 (90.0) | 27 (45.0) | <0.001 |
| Cervical cancer risk factors[ | |||
| Early sexual debut (correctly responded yes) | 85 (70.8) | 56 (93.3) | 0.001 |
| Smoking (correctly responded yes) | 62 (51.7) | 33 (55.0) | 0.792 |
| Multiple sexual partners (correctly responded yes) | 90 (75.0) | 49 (81.7) | 0.414 |
| Male partner with multiple partners (correctly responded yes) | 101 (84.2) | 49 (81.7) | 0.832 |
Significance is at p ≤ 0.05.
Correctly answered yes.
Comparison of Knowledge of Symptom Profile, Treatment, and Screening Modalities for Cervical Cancer
| Variable | Vaccinated | p[ | |
|---|---|---|---|
| No ( | Yes ( | ||
| Participants, | |||
| Correct responses for symptom profile of cervical cancer | |||
| Early stage (correctly responded yes) | |||
| Few symptoms | 10 (8.3) | 2 (3.3) | 0.342 |
| Late stage (correctly responded yes) | |||
| Lower abdominal pain | 69 (57.5) | 47 (78.3) | 0.010 |
| Vaginal bleeding | 73 (60.8) | 38 (63.3) | 0.871 |
| Vaginal discharge | 75 (62.5) | 35 (58.3) | 0.705 |
| Anemia | 43 (35.8) | 26 (43.3) | 0.416 |
| Postcoital bleeding | 61 (50.8) | 37 (61.7) | 0.224 |
| Urine and fecal incontinence | 38 (31.7) | 30 (50.0) | 0.026 |
| Weakness | 78 (65.0) | 45 (75.0) | 0.234 |
| Correct responses for treatment options | |||
| Chemotherapy (correctly responded yes) | 22 (18.3) | 46 (76.7) | <0.001 |
| Radiation (correctly responded yes) | 9 (7.5) | 29 (48.3) | <0.001 |
| Surgery (correctly responded yes) | 18 (15.0) | 36 (60.0) | <0.001 |
| Don't know | 79 (65.8) | 5 (8.3) | <0.001 |
| Correct responses for screening options | |||
| Blood tests (correctly responded no) | 40 (33.3) | 32 (53.3) | 0.015 |
| Pap smear (correctly responded yes) | 11 (9.2) | 10 (16.7) | 0.218 |
| VIA (correctly responded yes) | 13 (10.8) | 7 (11.7) | >0.999 |
| Don't know | 60 (50.0) | 21 (35.0) | 0.080 |
Significance is at p ≤ 0.05.
VIA, visual inspection with acetic acid.
Predictors of Knowledge of Cervical Cancer Derived by Logistics Regression Analysis
| Variable | Unadjusted | Adjusted |
|---|---|---|
| OR[ | OR[ | |
| Vaccinated | 14.7 (12.6–16.8) | 14.4 (12.2–16.7)[ |
| Grade 8 | 5.3 (2.5–8.1) | 0.7 (−1.4 to 2.9) |
OR: subject to logistic regression, only a positive vaccination status was the true predictor of knowledge of cervical cancer, with being a student in grade 8 not increasing the chance of being knowledgeable.
Significance is at p ≤ 0.05.
CI, confidence interval; OR, odds ratio.
Comparison of Source of Information for Cervical Cancer Among Participants Unvaccinated and Vaccinated Against Human Papillomavirus
| Variable | Vaccinated | p | |
|---|---|---|---|
| No ( | Yes ( | ||
| Participants, | |||
| Source of information[ | |||
| Community outreach program | 2 (3.3) | 4 (6.9) | 0.431 |
| Doctor | 5 (8.2) | 13 (22.4) | 0.040 |
| Social media | 19 (31.1) | 13 (22.4) | 0.308 |
| Family member/friend suffered from it | 11 (18.0) | 11 (19.0) | >0.999 |
| School Health Talk | 22 (36.1) | 20 (34.5) | >0.999 |
Significance is at p ≤ 0.05.
Number of participants selecting the option best applicable to them.
Comparison of Acceptability of Prevention Strategies for Cervical Cancer Among Participants Unvaccinated or Vaccinated Against Human Papillomavirus
| Variable[ | Vaccinated | p | |
|---|---|---|---|
| No ( | Yes ( | ||
| Participants, | |||
| Self-perceived risk of HPV infection | 27 (22.5) | 32 (53.3) | <0.001 |
| Acceptable age of sexual debut (years) | |||
| 10–20 | 2 (1.7) | 0(0.0) | 0.553 |
| 21–30 | 68 (56.7) | 32 (53.3) | 0.791 |
| ≥31 | 50 (41.7) | 28 (46.7) | 0.632 |
| Acceptable frequency of using condom ( | |||
| Always | 87 (73.7) | 41 (68.3) | 0.561 |
| Sometimes | 21 (17.8) | 12 (20.0) | 0.878 |
| Never | 10 (8.5) | 7 (11.7) | 0.678 |
| Would agree to receive HPV vaccine ( | 75 (63.6) | ||
| Would agree to be screened for cervical cancer | 102 (85.0) | 52 (86.7) | 0.940 |
| Vaccination protects you from all STI so no need for safe sex practices[ | 11 (18.3) | ||
Significance is at p ≤ 0.05.
Number of participants selecting the option best acceptable to them.
Use of the male condom. Figures do not add up to 180 as 2 girls did not respond.
Figures do not add up to 120 as 2 girls did not respond.
Based on the opinion of only the girls vaccinated on the kind of protection they now have through vaccination.
STI, sexually transmitted infection.